15 articles reviewed and scored below the CED clinical relevance threshold of 40. Included here for completeness. Some may still be relevant to your situation.
PolicyResearchIndustry
Germany’s Medical Cannabis Boom: Data-Driven Insights for Investors | INN
Germany’s medical cannabis market is experiencing significant growth, with real-world data from hundreds of patients providing insights into therapeutic effectiveness and market trends. Bloomwell’s analysis of anonymized patient data offers policymakers and investors evidence-based understanding of how medical cannabis is being utilized in clinical practice.
Real-world evidence from Germany’s expanding medical cannabis program demonstrates measurable therapeutic outcomes that can inform both regulatory decisions and investment strategies in the European market.
CBDResearchSleep
New study reveals how many Americans use CBD — and why | GreenState
A new study documents the prevalence and patterns of CBD use across the American population, finding the cannabinoid is utilized by diverse demographics for various purposes including sleep improvement and wellness applications. The research provides epidemiological data on how widespread CBD consumption has become among older adults and consumers seeking complementary health interventions.
Recent population-level data quantifies CBD adoption trends across demographic groups and use cases, offering insights into consumer behavior and the therapeutic contexts driving cannabinoid product uptake in the United States.
CBDSleepResearch
Why CBD Tinctures Are Becoming the Go-To Wellness Solution in 2026 – Breaking AC
CBD tinctures interact with the endocannabinoid system to regulate mood, sleep, appetite, and inflammation, making them increasingly popular as a wellness product in 2026. Their growing adoption reflects consumer interest in cannabinoid-based solutions for managing various physiological functions.
CBD tinctures’ mechanism through endocannabinoid system modulation represents a clinically relevant approach to wellness management that warrants continued research into efficacy and optimal dosing protocols.
PainAnxietySafety
CBD for pets: How CBD is transforming pet care and offering comfort – Upworthy
CBD for pets functions by interacting with the animal’s endocannabinoid system to produce therapeutic effects that may improve comfort and well-being. Current evidence suggests CBD may benefit pets experiencing pain, anxiety, and other conditions, though more clinical research is needed to establish optimal dosing and safety profiles in veterinary medicine.
CBD’s interaction with pets’ endocannabinoid systems shows promise for managing pain and anxiety in animals, but veterinarians need standardized dosing protocols and additional clinical trials before making definitive therapeutic recommendations.
** ResearchIndustry
Calyx Containers Announces Research Partnership With Cannabis Research Coalition to …
** Calyx Containers has partnered with the Cannabis Research Coalition to develop standardized post-harvest handling protocols that maintain product consistency and quality. The collaboration aims to establish evidence-based practices that prevent degradation of cannabis compounds during storage and transportation.
**
** Post-harvest container technology and storage conditions significantly influence cannabinoid stability and the therapeutic profile of cannabis products available to patients and consumers. **
CBDSafetyTesting Standards
Charlotte’s Web CBD Review: Products, Testing Standards & Our Experience – Forbes
Charlotte’s Web CBD products underwent third-party testing that confirmed the absence of detectable THC in samples, meeting stated product specifications. The review evaluated the company’s cannabinoid profile and testing standards to assess product quality and safety.
Third-party testing of Charlotte’s Web CBD products validated non-detectable THC levels, supporting the reliability of the company’s quality assurance practices.
PainCBDTHC
Seeking Pain Relief: How Effective Are Marijuana Gummies? [7zVpUcLY7QC]
Cannabis-infused gummies are increasingly used for pain management as marijuana legalization expands across medical and recreational markets. Current evidence suggests cannabinoid products may provide pain relief for some patients, though efficacy varies based on individual factors, dosing, and the specific type and ratio of cannabinoids used.
The clinical evidence for cannabis gummies in pain management remains mixed, with efficacy heavily dependent on individual cannabinoid sensitivity, consistent dosing practices, and the underlying pain condition being treated.
IndustryPolicy
Trulieve Cannabis Just Got Louder: What TRUL’s Shake-Up Means for You
Trulieve’s recent organizational changes reflect ongoing consolidation in the U.S. cannabis retail market, with the company maintaining significant brand recognition and market share despite competitive pressures. The shake-up signals potential shifts in operational strategy that may affect product availability and pricing for consumers across Trulieve’s retail footprint.
Trulieve’s internal restructuring underscores the evolving competitive landscape of legal cannabis retail and the financial pressures facing large-scale operators in an increasingly saturated market.
HempTHCIndustry
Exhale Wellness Announces Two New THCA Vape Cartridges: Birthday Cake and Berry Gelato
Exhale Wellness has released two new THCA vape cartridges formulated with hemp-derived THCa, Delta-8 THC, and natural terpenes while maintaining compliance with federal regulations by keeping Delta-9 THC content below 0.3%. These products represent the expanding market for federally legal cannabinoid alternatives to traditional cannabis.
The introduction of THCA vape products with compliant Delta-9 THC levels highlights the ongoing development of hemp-derived cannabinoid formulations in response to evolving federal regulatory frameworks.
PolicySafetyPediatrics
San Antonio schools see spike in THC vapes on campus – MySA
San Antonio school districts are experiencing a significant increase in THC vape violations, with felony cases skyrocketing and over 2% of high school students caught with the devices on campus. This trend reflects a broader youth access problem to concentrated cannabis products that are easily concealable and perceived as lower risk than traditional cannabis.
The rising prevalence of THC vapes in schools highlights the challenge of preventing youth access to highly potent cannabis products that are often misperceived as safer alternatives.
IndustryPolicy
Even with Auto-Enrollment, Cannabis Workers Are Rejecting 401(k)s – mg Magazine
A study examining retirement plan participation in the cannabis industry found that only 39 percent of workers are enrolled in 401(k) plans despite auto-enrollment features and competitive plan designs. The low participation rate suggests systemic barriers specific to the cannabis workforce may limit retirement savings adoption even when structural incentives are in place.
Low 401(k) enrollment among cannabis workers despite auto-enrollment policies indicates industry-specific challenges in financial security and workforce retention that extend beyond typical retirement plan participation rates.
PolicySafety
Accused notary for Nebraska medical cannabis petitions takes stand in criminal trial
A notary public in Nebraska accused of falsifying medical cannabis petition signatures testified in his criminal trial as prosecutors allege he fraudulently notarized documents related to the state’s 2024 medical cannabis initiative. The case centers on whether Todd improperly certified signatures on petitions submitted to advance cannabis legalization in the state.
A Nebraska notary faces criminal charges for allegedly falsifying signatures on medical cannabis legalization petitions, raising questions about document verification processes in ballot initiatives.
Mental HealthSafety
Crazy how once you’re sober, you realize how depressed marijuana made you. : r/leaves
Some cannabis users report experiencing depression that they only recognize after discontinuing use, suggesting a potential link between regular marijuana consumption and mood disorders. This observation from abstinent users highlights the importance of monitoring mental health changes associated with cannabis cessation and ongoing use.
Regular cannabis users may not recognize depression symptoms while actively using, but experience improved mood clarity upon discontinuation, raising questions about cannabis’s direct effects on depression versus masking underlying symptoms.
PolicyIndustry
Marijuana – The Virginian-Pilot
Law enforcement in Suffolk, Virginia discovered a marijuana operation following an accidental gunshot incident in August 2019. The discovery led to charges related to cannabis cultivation and possession.
An unintended firearm discharge resulted in the identification of an illicit cannabis growing operation in Virginia, highlighting how law enforcement investigations can uncover drug-related activities through unexpected circumstances.
President Donald Trump’s State of the Union address broke the record for length. Here’s …
Outside of Northside Independent School District headquarters in San Antonio, where THC vape cases are · Grass fire shuts down notorious Central Texas …
Digest-Level Clinical Commentary
These items underscore three clinical priorities for cannabis medicine practitioners: the urgent need for standardized safety testing and quality control frameworks as consumption patterns expand across diverse populations (particularly older adults and pediatric exposures), the importance of screening for cannabis-induced mood disorders alongside pain and sleep indications, and the critical gap between widespread product availability and robust clinical evidence supporting safety and efficacy claims. The prevalence of federally legal cannabinoid alternatives and concentrated products entering community settings demands that we establish clearer risk-benefit conversations with patients while advocating for research standards that match the scale of current use patterns.
Clinical Perspective
These items reflect several clinically relevant trends: the growing prevalence of CBD and cannabinoid use among adult populations for symptom management (sleep, pain, anxiety), emerging safety and quality assurance questions around product testing and storage, and a significant public health concern regarding youth access to concentrated THC products in educational settings. The evidence base remains limited for most therapeutic claims, particularly regarding long-term safety and efficacy in both human and veterinary applications, underscoring the need for rigorous clinical research to inform patient counseling and policy decisions.
CBD
PolicySafetyIndustry💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
